Literature DB >> 29038892

[Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].

M Zamperetti1, B Zelger2, R Höpfl2.   

Abstract

We report on a 21-year-old woman with a 3-year history of crusts and erosions on her scalp that had appeared after starting treatment with adalimumab due to Crohn's disease. By clinicopathological correlation pityriasis amiantacea with underlying folliculitis decalvans was diagnosed. Topical and systemic antibiotic treatment showed rapid response. The occurrence of pityriasis amiantacea in folliculitis decalvans associated with tumor necrosis factor (TNF)-α inhibitor therapy is remarkable and highlights the ambivalent role of TNF-α in diseases with immunological dysfunctions in combination with infections.

Entities:  

Keywords:  Alopecia; Crohn disease; Hair diseases; Scalp; Treatment

Mesh:

Substances:

Year:  2017        PMID: 29038892     DOI: 10.1007/s00105-017-4067-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  Pityriasis amiantacea: a distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy.

Authors:  J Ettler; D A Wetter; M R Pittelkow
Journal:  Clin Exp Dermatol       Date:  2012-02-02       Impact factor: 3.470

Review 2.  Lichen planopilaris.

Authors:  Hoon Kang; Abdullateef A Alzolibani; Nina Otberg; Jerry Shapiro
Journal:  Dermatol Ther       Date:  2008 Jul-Aug       Impact factor: 2.851

3.  Therapy-resistant folliculitis decalvans and lichen planopilaris successfully treated with adalimumab.

Authors:  Katharina Kreutzer; Isaak Effendy
Journal:  J Dtsch Dermatol Ges       Date:  2013-10-11       Impact factor: 5.584

4.  Treatment of pityriasis amiantacea with infliximab.

Authors:  Ryan K Pham; C Stanley Chan; Sylvia Hsu
Journal:  Dermatol Online J       Date:  2009-12-15

5.  Pityriasis amiantacea: a clinical and histopathological investigation.

Authors:  A G Knight
Journal:  Clin Exp Dermatol       Date:  1977-06       Impact factor: 3.470

6.  Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings.

Authors:  J J Powell; R P Dawber; K Gatter
Journal:  Br J Dermatol       Date:  1999-02       Impact factor: 9.302

Review 7.  Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review.

Authors:  Mio Nakamura; Kristina Lee; Rasnik Singh; Tian Hao Zhu; Benjamin Farahnik; Michael Abrouk; John Koo; Tina Bhutani
Journal:  J Dermatolog Treat       Date:  2016-09-15       Impact factor: 3.359

Review 8.  The Diagnosis and Treatment of Hair and Scalp Diseases.

Authors:  Hans Wolff; Tobias W Fischer; Ulrike Blume-Peytavi
Journal:  Dtsch Arztebl Int       Date:  2016-05-27       Impact factor: 5.594

9.  Immunopathogenesis of folliculitis decalvans: clues in early lesions.

Authors:  Caterina Chiarini; Daniele Torchia; Beatrice Bianchi; Walter Volpi; Marzia Caproni; Paolo Fabbri
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

10.  Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.

Authors:  Cornelia Tillack; Laura Maximiliane Ehmann; Matthias Friedrich; Rüdiger P Laubender; Pavol Papay; Harald Vogelsang; Johannes Stallhofer; Florian Beigel; Andrea Bedynek; Martin Wetzke; Harald Maier; Maria Koburger; Johanna Wagner; Jürgen Glas; Julia Diegelmann; Sarah Koglin; Yvonne Dombrowski; Jürgen Schauber; Andreas Wollenberg; Stephan Brand
Journal:  Gut       Date:  2013-03-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.